Advanced Insulin Therapy: Beyond the Basics
Recorded Session from the AANP 2018 National Conference
Release Date: October 22, 2018
Expiration Date: October 31, 2019 (subject to change)
Conference Level: Proficient
- CE for this activity will not be available after this date.
The incidence and prevalence of diabetes is growing by leaps and bounds. Because of this, more and more family nurse practitioners will be managing diabetes in primary care setting. The latest evidence shows that less than 50% of patients with diabetes are meeting glycemic targets. Therefore, it is now more important than ever that NPs have the education, skills, resources and finesse to know when and how to intensify insulin therapy. Diabetes is a condition characterized by progressive loss of beta cell mass and function resulting in most patients requiring insulin to achieve glycemic targets. Despite these findings, there is hesitation by both primary care providers and patients to initiate insulin and to intensify the insulin therapy regimen commonly called clinical inertia. Lack of knowledge and experience with the use of insulin is a contributing factor to clinical inertia.
This presentation explores various strategies for intensification of insulin therapy in both Type 1 and Type 2 Diabetes including the concepts of carbohydrate counting, multi-daily dose adjustments and ongoing modifications in insulin doses to get patients to target. The cost, efficacy, safety and prevention of hypoglycemia are covered in addition to education for self-management insulin administration. The presentation touches on the new insulin formulations. Case studies will be presented to demonstrate key concepts.
This CE activity is a recording of a CE session from the AANP 2018 National Conference. It has been edited to meet the format requirements for online learning. If you received CE credit for attending the live session at Conference, you many not receive duplication credit for this same activity in a different format.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete the educational content completely:
- Video Presentations: Watch all video presentations completely.
- Review all additional materials provided (handouts, posttest reviews, all other downloadable resources).
- After completing all content, go to Steps to Receive Credit to complete the posttest and evaluation to receive full AANP CE/Rx credit. If other types of credit are offered, these options will be available after completing the activity evaluation.
- Understand the logistics of basal/bolus therapy
- Understand strategies for adjusting insulin and basic pattern management using case studies
- Verbalize the patient and provider resources available for insulin therapy treating and preventing hypoglycemia
Angela Thompson, DNP, FNP-C, B-ADM, CDE, FAANP
This activity was planned in accordance with AANP Accreditation Standards and Policies. Dr. Thompson has no relevant affiliations to disclose.
This educational activity may contain opinions of the speakers from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
For questions about this online CE activity, or more information concerning the AANP CE Center, contact the AANP CE Center Manager at CECenter@aanp.org.
|1 Contact Hour(s) of CE,
All of which may be applied towards Pharmacology
Additional CE activities of interest
Starting & Adjusting Insulin in Type 2 Diabetes in Primary Care
What's Next? Using Injectable Therapies in Type 2 Diabetes
Improving Care and Outcomes in Type 2 Diabetes: A Nurse Practitioner-Led Charge for Overcoming Insulin Inertia
Next Generation Diabetes Management: Titratable Fixed-Ratio Combination Therapy with Basal Insulin/GLP-1 RA to Better Manage Type 2 Diabetes